AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $992 | +104.5% | 127,728 | +154.8% | 0.00% | – |
| Q2 2023 | $485 | -34.9% | 50,134 | -26.2% | 0.00% | – |
| Q1 2023 | $745 | +167.0% | 67,953 | +5.0% | 0.00% | – |
| Q4 2022 | $279 | -100.0% | 64,723 | -90.1% | 0.00% | -100.0% |
| Q3 2022 | $4,940,000 | -52.8% | 656,802 | -36.9% | 0.01% | -16.7% |
| Q2 2022 | $10,464,000 | +90.5% | 1,041,054 | +134.6% | 0.01% | +50.0% |
| Q1 2022 | $5,494,000 | -80.9% | 443,798 | -64.7% | 0.00% | -33.3% |
| Q4 2021 | $28,720,000 | +118.2% | 1,255,814 | +111.1% | 0.01% | 0.0% |
| Q3 2021 | $13,163,000 | +432.1% | 594,806 | +211.7% | 0.01% | +500.0% |
| Q2 2021 | $2,474,000 | -54.1% | 190,856 | -54.0% | 0.00% | -66.7% |
| Q1 2021 | $5,393,000 | +145.2% | 415,260 | +161.1% | 0.00% | +200.0% |
| Q4 2020 | $2,199,000 | -32.8% | 159,024 | -28.4% | 0.00% | -50.0% |
| Q3 2020 | $3,270,000 | +159.1% | 222,024 | +185.8% | 0.00% | +100.0% |
| Q2 2020 | $1,262,000 | +12.0% | 77,686 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $1,127,000 | -51.3% | 77,686 | -32.0% | 0.00% | 0.0% |
| Q4 2019 | $2,316,000 | +103.7% | 114,275 | -46.3% | 0.00% | – |
| Q3 2019 | $1,137,000 | +28325.0% | 212,760 | +31798.1% | 0.00% | – |
| Q2 2019 | $4,000 | -33.3% | 667 | -32.6% | 0.00% | – |
| Q1 2019 | $6,000 | -99.1% | 990 | -99.0% | 0.00% | – |
| Q4 2018 | $682,000 | +2.7% | 100,000 | 0.0% | 0.00% | – |
| Q3 2018 | $664,000 | – | 100,000 | +333233.3% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 30 | -97.1% | 0.00% | – |
| Q1 2018 | $5,000 | -95.8% | 1,020 | -94.7% | 0.00% | – |
| Q3 2017 | $120,000 | +605.9% | 19,100 | +582.1% | 0.00% | – |
| Q2 2017 | $17,000 | – | 2,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |